TrialEuropean journal of neurology2024

A multicenter, randomized, open-label, phase 2 clinical study of telitacicept in adult patients with generalized myasthenia gravis.

Jian Yin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.